Evidence map›Paper›PMID 33483724›Full record

ReviewCardiovascular research2021

Reciprocal organ interactions during heart failure: a position paper from the ESC Working Group on Myocardial Function.

Michele Ciccarelli, Dana Dawson, Inês Falcao-Pires, Mauro Giacca, Nazha Hamdani, Stéphane Heymans, Astrid Hooghiemstra, Annebet Leeuwis, Dorien Hermkens, Carlo Gabriele Tocchetti and 3 more

Open access · bronzeAbstract readReviewConsensus Statement
In one paragraph

Review in Cardiovascular research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Prevotellaceae Modulates Colorectal Cancer Immune Microenvironment to Assist Anti-PD-L1 Immunotherapy.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 8 countries.

Michele CiccarelliUniversity of Salerno, Department of Medicine, Surgery and Dentistry, Via S. Allende 1, 84081, Baronissi(Salerno), Italy.ORCID 0000-0003-2379-1960
Dana DawsonSchool of Medicine and Dentistry, University of Aberdeen, Aberdeen AB25 2DZ, UK.ORCID 0000-0003-2815-4469
Inês Falcao-PiresDepartment of Surgery and Physiology, Cardiovascular Research and Development Center, Faculty of Medicine of the University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal.ORCID 0000-0003-1937-3782
Mauro GiaccaKing's College London, Molecular Medicine Laboratory, 125 Caldharbour Lane, London WC2R2LS, United Kingdom.ORCID 0000-0003-2927-7225
Nazha HamdaniDepartment of Clinical Pharmacology and Molecular Cardiology, Institute of Physiology, Ruhr University Bochum, Universitätsstraße 150, D-44801 Bochum, Germany.
Stéphane HeymansCentre for Molecular and Vascular Biology, KU Leuven, Herestraat 49, Bus 911, 3000 Leuven, Belgium.
Astrid HooghiemstraDepartment of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, De Boelelaan 1118, 1081HZ, Amsterdam, The Netherlands.ORCID 0000-0002-3652-6640
Annebet LeeuwisDepartment of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, De Boelelaan 1118, 1081HZ, Amsterdam, The Netherlands.ORCID 0000-0003-4162-1738
Dorien HermkensDepartment of Pathology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands.
Carlo Gabriele TocchettiDepartment of Translational Medical Sciences and Interdepartmental Center of Clinical and Translational Research (CIRCET), Federico II University, Naples, Italy.ORCID 0000-0001-5983-688X
Jolanda van der VeldenAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Physiology, Amsterdam Cardiovascular Sciences, De Boelelaan 1118, 1081HZ Amsterdam, the Netherlands.ORCID 0000-0001-5224-5788
Serena ZacchignaDepartment of Medicine, Surgery and Health Sciences, University of Trieste, Strada di Fiume, 447, 34129 Trieste, Italy.ORCID 0000-0001-6705-3076
Thomas ThumInstitute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany.ORCID 0000-0003-4360-1511
Amsterdam Neuroscience · NLUniversity of Trieste · ITAmsterdam University Medical Centers · NLFederico II University Hospital · ITMaastricht University · NLMedizinische Hochschule Hannover · DESt. Josef-Hospital · DEUniversidade do Porto · PTUniversity of Aberdeen · GBUniversity of Salerno · IT

Funding

AIRC IG 2016 19032BHF Project PG/17/64/33205British Heart FoundationCVON 2018-28 & 2012-06 Heart Brain ConnectionCVON Arena-PRIME, 2017-18CVON-Dosis 2014-20CVON She-PREDICTSDeutsche Forschungsgemeinschaft KFO311/TH903/20Dutch Federation of University Medical CentresERA-Net-CVD project MacroERA 01KL1706EU Horizon 2020 project CARDIOREGENIX (GA 825670European Structural and Investment FundsEuropean Union Commission's Seventh Framework program GA 305507IMI2-CARDIATEAM 821508Lisbon's Regional Operational Program 2020Netherlands Cardiovascular Research Initiative-an initiative with support of the Dutch Heart Foundation CVON2016-Early HFPEF, 2015-10Netherlands Organisation for Health Research and Development and the Royal Netherlands Academy of SciencesNetherlands Organization for Sciences-ZonMW (VICI 91818602Portuguese Foundation for Science and TechnologyProject NETDIAMOND POCI-01-0145-FEDER-016385Research Foundation Flanders FWO G091018N
6 · The paper itself

Abstract

Heart failure-either with reduced or preserved ejection fraction (HFrEF/HFpEF)-is a clinical syndrome of multifactorial and gender-dependent aetiology, indicating the insufficiency of the heart to pump blood adequately to maintain blood flow to meet the body's needs. Typical symptoms commonly include shortness of breath, excessive fatigue with impaired exercise capacity, and peripheral oedema, thereby alluding to the fact that heart failure is a syndrome that affects multiple organ systems. Patients suffering from progressed heart failure have a very limited life expectancy, lower than that of numerous cancer types. In this position paper, we provide an overview regarding interactions between the heart and other organ systems, the clinical evidence, underlying mechanisms, potential available or yet-to-establish animal models to study such interactions and finally discuss potential new drug interventions to be developed in the future. Our working group suggests that more experimental research is required to understand the individual molecular mechanisms underlying heart failure and reinforces the urgency for tailored therapeutic interventions that target not only the heart but also other related affected organ systems to effectively treat heart failure as a clinical syndrome that affects and involves multiple organs.

Indexed as

AnimalsDisease ProgressionFunctional StatusHeartHeart Failure, DiastolicHeart Failure, SystolicHumansMultiple Organ FailureRisk AssessmentRisk FactorsAdipose tissueBrainHeart failureIntestineKidneyLiverLungMulti-organ clinical syndromeNon-coding RNAs

Identifiers

PMID33483724
PMCPMC8562335
OpenAlexW3124991957

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.